beta
Trial Radar AI
Clinical Trial NCT07475741 (Exergaming) for Parkinsons Disease (PD) is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Exergaming for Imrpving Upper Limb Functions in Parkinson's Disease 30 Randomized Real-World Evidence

Recruiting
Clinical Trial NCT07475741 (Exergaming) is an interventional study for Parkinsons Disease (PD) that is recruiting. It started on 20 February 2026 with plans to enroll 30 participants. Led by University of Health Sciences Lahore, it is expected to complete by 1 November 2026. The latest data from ClinicalTrials.gov was last updated on 16 March 2026.
Brief Summary
Parkinson's Disease commonly results in impaired hand dexterity, reducing a patient's ability to perform activities of daily living. While digital exergaming has been used to encourage physical activity and improve motor function, it often lacks real-world tactile engagement. Integrating physical objects into exergaming known as a phygital approach which may enhance sensorimotor learning and functional carryover. How...Show More
Detailed Description
Upper limb motor impairments in Parkinson's Disease significantly affect daily functioning and independence . While digital exergaming has emerged as a promising tool in neurorehabilitation, traditional models often rely solely on screen-based interaction and lack real-world physical engagement. Recent studies have highlighted the need to include tactile and sensory feedback to improve functional relevance and user e...Show More
Official Title

Exergaming With Physical Onjects for Upper Limb Rehabilitation in Parkinson's Disease: Effects on Functional Outcome

Conditions
Parkinsons Disease (PD)
Other Study IDs
  • Exergaming
  • UHS/DPS-25/1158
NCT ID Number
NCT07475741
Start Date (Actual)
2026-02-20
Last Update Posted
2026-03-16
Completion Date (Estimated)
2026-11
Enrollment (Estimated)
30
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Keywords
Exergaming
Parkinson Disease
Physical Therapy
Upper Limb Rehabilitation
Primary Purpose
Treatment
Design Allocation
Randomized
Interventional Model
Parallel
Masking
Double
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Active ComparatorControl Group (Conventional Physical Therapy Group)
It will act as control group. The participants in this control group will receive the 36 sessions (three sessions per week over 12 weeks), each lasting approximately 30 minutes).
Conventional Physical Therapy
Patients will receive routine physiotherapy treatment based on the impairments: Strength Training Flexibility and Mobility Balance and Coordination Gait and Functional Training Conentional Physical Therapy
ExperimentalPhygital Group (Exergamig)
The intervention group (phygital) will receive thirty six sessions (three sessions per week over twelve weeks), each lasting approximately 30 minutes, involving structured exergaming tasks using physical objects (e.g., blocks, spoons, cups) combined with digital prompts on a tablet or laptop.
Exergaming
The intervention group (phygital) will receive 36 sessions (three sessions per week over twelve weeks), each lasting approximately 30 minutes, involving structured exergaming tasks using physical objects (e.g., blocks, spoons, cups) combined with digital prompts on a tablet or laptop.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Box and Block Test
The Box and Block Test (BBT) is a 60-second, standardized, unilateral assessment measuring gross manual dexterity in individuals with Parkinson's Condition
Baseline Measurements at day 1 will be taken prior to the interventions, and late Post-treatment after 12 weeks of intervention, another assessment will be taken. At followup visits, the consistency in the improvement will be assessed.
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
45 Years
Eligible Sexes
All
  • Early-stage Parkinson's Disease from I-III of Hoehn and Yahr scale
  • Cognitinve Assessment MMSE >= 24 Score
  • Able to communicate and understand the commands
  • Must be on regular use of Levodopa/carbidopa

  • Advanced stage IV or V
  • Patients with severe cognitive deficits.
  • History of suffering from other neurological or musculoskeletal conditions affecting hand use for the exercise
  • Not taking any medicine for systemic illness
University of Health Sciences Lahore logoUniversity of Health Sciences Lahore
Punjab Institute of Neurosciences Lahore logoPunjab Institute of Neurosciences Lahore
Study Responsible Party
Hafiz Muddassir Riaz, Principal Investigator, Lecturer, University of Health Sciences Lahore
Study Central Contact
Contact: Hafiz Muddassir Riaz, Ph.D Scholar, +92345-6627409, [email protected]
1 Study Locations in 1 Countries

Punjab Province

Punjab institute of Neuroscience Lahore, Lahore, Punjab Province, 54000, Pakistan
Prof. Dr. Mohsin Zaheer, FCPS, Contact, +924299268855, [email protected]
Hafiz Muddassir Riaz, Ph.D Scholar, Principal Investigator
Recruiting